Kathryn Jo Petrucci from 15436 Las Manzanitas Rd, Ramona, CA 92065, age 56

Name / Title

Company / Classification

Phones & Addresses

Kathryn J. Petrucci
Chief Executive Officer, President

Animal Cell Therapies, Inc
Testing Laboratory

11211 Sorrento Vly Rd, San Diego, CA 92121
2156 Cambridge Ave, Cardiff by the Sea, CA 92007

Kathryn Petrucci
President, Founder, Chief Medical Officer , Principal

Animal Cell Therapies
Biotechnology · General Hospital · Veterinary Services

10054 Mesa Rdg Ct SUITE 106, San Diego, CA 92121
836 Prospect St, La Jolla, CA 92037
10064 Mesa Rdg Ct, San Diego, CA 92121
8586788843

Synthetic Glycoamine Compounds
view source
US Patent:

20130196935, Aug 1, 2013
Filed:

Jan 28, 2013
Appl. No.:

13/751581
Inventors:

Animal Cell Therapies Inc. - San Diego CA, US
Kathryn J. Petrucci - La Jolla CA, US
Xueliang Tao - San Diego CA, US
Assignee:

ANIMAL CELL THERAPIES INC. - San Diego CA
International Classification:

C07H 7/04
A61K 45/06
A61K 31/7012
US Classification:

514 23, 536 187
Abstract:

This disclosure is directed to synthetic glycoamine compounds and pharmaceutical compositions containing such compounds. The synthetic glycoamine compounds provided here can affect cell adhesion and induce apoptosis, and are useful in treating metastatic diseases and cancer.

Stem Cells And Methods Of Using Them
view source
US Patent:

20200046776, Feb 13, 2020
Filed:

Aug 8, 2019
Appl. No.:

16/535663
Inventors:

- San Diego CA, US
Kathryn J. Petrucci - La Jolla CA, US
International Classification:

A61K 35/32
A61K 38/17
Abstract:

This document relates to materials and methods involved in assessing and using stem cells. For example, materials and methods for determining if a stem cell (e.g., a mesenchymal stem cell) has an increased proliferation rate and/or an increased potential to differentiate into a bone cell are provided.